Practice question

Answer the question and get instant feedback.

MediumKDIGO and ADA/KDIGO consensus recommend ns‑MRA (e.g. finerenone) for persistent albuminuria despite ACEi/ARB and SGLT2 inhibitorCKD G3b A3KDIGO guideline (2024): evaluation and management of chronic kidney disease

A 68-year-old with T2D and CKD G3b A3 (eGFR 38, ACR 520 mg/g) is on maximized ACE inhibitor and SGLT2 inhibitor. Potassium 4.6 mEq/L. Next kidney-protective add-on?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.